Platycodin D ameliorates antibiotic-associated diarrhea by modulating the PI3K/AKT/NF-κB pathway and regulating gut microbiota and metabolism
International Immunopharmacology · 2026-07 · 181 · 116748
DOI: 10.1016/j.intimp.2026.116748 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-07. Verfasst von Mohan Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Agriculture, Yanbian University, Jilin Province, Yanji 133002, China. Hauptthemen laut MEDLINE: Triterpenes, Saponins, Anti-Bacterial Agents, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program, Yanbian University.
Abstract (Originalsprache)
Antibiotic-associated diarrhea (AAD) is a clinical condition characterized by diarrhea, vomiting, and fever, typically resulting from inappropriate or excessive use of antibiotics. Platycodin D (PD), a major bioactive compound of Platycodon grandiflorum, exhibits antioxidant, anti-inflammatory, and antitumor activities. However, whether PD can mitigate AAD remains unclear, and its effects on gut microbiota and metabolites have not been extensively studied. To address this knowledge gap, we established an AAD mouse model to investigate the effects and underlying mechanisms of PD through assessments of clinical indicators, biochemical parameters, histopathology, gut microbiota, and metabolomics. Our results demonstrated that PD supplementation significantly alleviated AAD symptoms in mice and improved intestinal barrier function, colonic inflammation, and oxidative stress. Western blot analysis revealed that PD mitigated AAD by modulating the PI3K/AKT/NF-κB and Nrf2/Keap1 signaling pathways. Furthermore, gut microbiota and metabolomic analyses indicated that PD improved the intestinal microbial composition, increased the Firmicutes-to-Bacteroidetes (F/B) ratio, and modulated several metabolic pathways, including D-amino acid metabolism, cysteine and methionine metabolism, and primary bile acid biosynthesis. In conclusion, these findings suggest that PD alleviates AAD through modulation of the PI3K/AKT/NF-κB and Nrf2/Keap1 pathways, as well as gut microbiota and metabolites, providing novel insights into the prevention and treatment of AAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Agriculture, Yanbian University, Jilin Province, Yanji 133002, China.
- College of Agriculture, Yanbian University, Jilin Province, Yanji 133002, China. Electronic address: 0000008592@ybu.edu.cn.
- College of Agriculture, Yanbian University, Jilin Province, Yanji 133002, China. Electronic address: 0000008711@ybu.edu.cn.
- Affiliated Hospital of Yanbian University, Jilin Province, Yanji 133000, China. Electronic address: tim-cn@163.com.
- College of Agriculture, Yanbian University, Jilin Province, Yanji 133002, China. Electronic address: jinqing@ybu.edu.cn.
Förderung
- Jilin Provincial Scientific and Technological Development Program
- Yanbian University
Zitieren
APA
Zhang, M., Qin, L., Yang, X., An, Q., Zou, Y., Wang, S., Piao, H., Wen, Y., Cui, H., & Jin, Q. (2026). Platycodin D ameliorates antibiotic-associated diarrhea by modulating the PI3K/AKT/NF-κB pathway and regulating gut microbiota and metabolism. International Immunopharmacology, 181, 116748. https://doi.org/10.1016/j.intimp.2026.116748
Vancouver
Zhang M, Qin L, Yang X, An Q, Zou Y, Wang S, et al. Platycodin D ameliorates antibiotic-associated diarrhea by modulating the PI3K/AKT/NF-κB pathway and regulating gut microbiota and metabolism. International Immunopharmacology. 2026;181:116748. doi:10.1016/j.intimp.2026.116748
BibTeX
@article{Zhang2026,
author = {Zhang, Mohan and Qin, Liwen and Yang, Xiao and An, Qi and Zou, Yanbing and Wang, Shuqi and Piao, Hongjie and Wen, Yuping and Cui, Hushan and Jin, Qing},
title = {Platycodin D ameliorates antibiotic-associated diarrhea by modulating the PI3K/AKT/NF-κB pathway and regulating gut microbiota and metabolism},
journal = {International Immunopharmacology},
year = {2026},
volume = {181},
pages = {116748},
doi = {10.1016/j.intimp.2026.116748}
}
EUVIMED